Lavimika 500mg Injection
Marketer
Lavish Biotech
Salt Composition
Amikacin (500mg)
Overview Lavimika 500mg Injection
Ceflavim 500mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, bones, joints, lungs (such as pneumonia), brain, and bloodstream. This antibiotic is also prophylactically administered to hospitalized patients to reduce infection risk. Ceflavim 500mg Injection inhibits bacterial growth. Administered intravenously (drip) or intramuscularly by a healthcare professional only, it requires strict adherence to the prescribed dosage schedule. Complete the entire course of treatment, even with symptom improvement, to prevent relapse. Premature discontinuation may result in infection recurrence or exacerbation. Typical side effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant immediate medical attention. High doses can potentially cause vertigo, nephrotoxicity, and ototoxicity. Your physician may conduct regular kidney, hearing, and urine tests. This medication is contraindicated during pregnancy; inform your doctor if pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Lavimika 500mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Lavimika 500mg Injection
Infections caused by bacteria
Major Benefits of Lavimika 500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Lavimika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Lavimika 500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Lavimika 500mg Injection works:
Bactistop 500mg Injection is a bactericidal medication. Its mechanism of action involves inhibiting the production of crucial bacterial proteins, thus hindering essential bacterial processes.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from combining Lavimika 500mg Injection with alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Lavimika 500mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in potentially life-threatening circumstances where the physician deems the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Lavimika, 500mg, presents minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, posing no known threat to the infant.
DrivingUNSAFE
Administering Lavimika 500mg Injection can reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when administering Lavimika 500mg Injection to individuals with impaired renal function. Dosage modification for Lavimika 500mg Injection may be necessary. A physician's guidance is recommended.
LiverSAFE IF PRESCRIBED
The use of Lavimika 500mg Injection in patients with liver impairment is likely safe. Available evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Lavimika 500mg Injection :
Omit a Lavimika 500mg Injection dose? Seek your physician's advice.
Facts to Know About Lavimika 500mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Active Class | Aminoglycoside antibiotics |
3,018 People bought this recently